medigraphic.com
SPANISH

Evidencia Médica e Investigación en Salud

ISSN 2007-6053 (Print)
Órgano oficial de difusión de los Hospitales Regionales de Alta Especialidad (HRAE)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2011, Number 1

<< Back Next >>

Evid Med Invest Salud 2011; 4 (1)

Epidemiology of cervical cancer mortality in Oaxaca, 2000-2010

García-Rojas MI, Mayoral-García M, Pintor-Sill JR, Malvaez-Montesanos N, Méndez-Méndez PM, Sánchez-Sánchez M, Velásquez-Paz A
Full text How to cite this article

Language: Spanish
References: 9
Page: 10-14
PDF size: 185.60 Kb.


Key words:

cervical cancerl, mortality, Oaxaca.

ABSTRACT

Introduction: Cervical cancer is a major public health problem among women in the world. In the state of Oaxaca, Mexico about 1,638 women are diagnosed annually with precancerous lesions, of which 236 cases are cancer in situ and 90 invasive cancer.
Material and methods: We analyzed the mortality from cervical cancer in Oaxaca from 2000 to 2010. We calculated crude rates and age-adjusted rates in women over 20 years, in addition to mortality rates by municipality and health jurisdiction.
Results: Deaths from cervical cancer registered from 2000 to 2010 were 2,303 cases. The trend in mortality rates was upward during the first 5 years, rising from 18.7 deaths per 100.000 women over 20 years old in 2000, to 23.2 and 21.5 in 2003 and 2004 respectively, decreasing to 17.4 in 2010. Sanitary Jurisdiction No. 1 was the highest number of cases of which, both Oaxaca de Juarez and Santa Cruz Xoxocotlán municipalities had more deaths.
Discussion: We need to generate new policies according our needs, changes in the mechanisms of quality control samples, regulate the practice of colposcopy, making continuing medical education programs and create our own scientific evidence for a correct decision-making in health.


REFERENCES

  1. Sankaranarayanan R, Madhukar BA, Rajkumar R. Effective screening programmers for cervical cáncer in low-and middle-income developing countries. Bulletin of the World Health Organization 2001; 79: 954-62.

  2. Tovar-Guzmán VJ , Ortiz-Contreras F, Jiménez-Gauna FR, Valencia-Vásquez G. Panorama epidemiológico de la mortalidad por cáncer cérvico uterino en México (1980-2004). Rev. Fac Med UNAM 2008; 51 (2): 47-51.

  3. Hernández-Peña P, Lazcano-Ponce EC, Alonso-de Ruíz P, Cruz-Valdez A, Meneses-González F, Hernández-Ávila M. Análisis costo beneficio del Programa de Detección Oportuna del Cáncer Cervicouterino. Salud Pública Mex Méx. 1997; 39: 379-387.

  4. Palacio-Mejía LS, Lazcano-Ponce E, Allen-Leigh B, Hernández-Ávila M. Diferencias regionales en la mortalidad por cáncer de mama y cérvix en México entre 1979 y 2006. Salud Pública Méx. 2009; 51 Supl 2: S208-S219.

  5. López-Saavedra A, Lizano-Soberón M. Cáncer cervicouterino y el virus del papiloma humano: la historia que no termina. Cancerología 2006; 1: 31-55.

  6. Sistema Estatal de Defunciones, Servicios de Salud de Oaxaca. 2009.

  7. Globocan 2008 (IARC). Section of Cancer Information (Internet). Consultado el 10 de febrero de 2011. Disponible en http://globocan.iarc.fr/factsheets/populations/ factsheet.asp?uno=900

  8. Índice de marginación a nivel localidad 2005. Consejo Nacional de Población (Internet). Consultado el 10 de febrero de 2011. Disponib le en www.conapo.gob.mx

  9. Alejandro Mohar. Prevención del cáncer cervical: el caso de los países en desarrollo. Salud Pública Méx. 2003; 45 (Supl 3): S302-S303.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Evid Med Invest Salud. 2011;4